EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Divergent HIV-1 Restriction Phenotypes of IFITMs Expressed in Target Cells and Incorporated into Virions

Smita Verma iD, David Prikryl, Mariana Marin, Ruben M Markosyan, Andrea Cimarelli, Gregory B Melikyan iD

Biomolecules · 18.03.2026 · 16 (3) · 459

DOI: 10.3390/biom16030459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 18.03.2026. Verfasst von Smita Verma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: HIV-1, Virion, Membrane Proteins, RNA-Binding Proteins. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANRS|MIE, National Institute of Allergy and Infectious Diseases, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon-induced transmembrane proteins (IFITMs) are broad-spectrum antiviral factors that restrict the entry of many enveloped viruses, including HIV-1, by modifying host membrane properties and trapping fusion at the hemifusion stage. Beyond blocking entry in target cells, IFITMs also reduce the infectivity of virions produced from IFITM-expressing cells, a phenomenon termed “negative imprinting”. Conserved motifs, such as the amphipathic helix and oligomerization motifs, have been reported to be essential for IFITM-mediated protection of target cells from viral infection. Yet, the impact of IFITM incorporation on progeny virion infectivity remains poorly defined. Here, we show that IFITM3 mutants defective in target cell protection activity still markedly impair HIV-1 fusion/infection upon incorporating into virions, without affecting viral maturation or Env incorporation. Immunofluorescence studies suggest mislocalization of the IFITM3 mutants as the reason for the lack of antiviral activity in target cells. Testing the antiviral activity of chimeras between antiviral and non-antiviral IFITM orthologs failed to clearly identify a domain responsible for reduction of HIV-1 infectivity, suggesting that multiple domains may be required for negative imprinting. Interestingly, co-incorporation of non-antiviral dog IFITM1 with human IFITM3 did not interfere with IFITM3’s negative imprinting activity, despite forming mixed hetero-oligomers. This finding implies a dominant, oligomerization-independent antiviral phenotype of IFITM3 in virions. Our findings suggest that IFITMs may protect target cells and negatively imprint progeny virions through distinct mechanisms, underscoring the need to further characterize the molecular basis for the reduced fusion competence of IFITM-containing HIV-1 particles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1VirionMembrane ProteinsRNA-Binding ProteinsHIV InfectionsHumansPhenotypeHEK293 CellsMutationDogsVirus InternalizationAntigens, Differentiation

Stichwörter der Autor:innen

HIV negative imprintingIFITM mutants and chimerassubcellular localizationtarget cell protectionviral fusion

Substanzen

Membrane ProteinsRNA-Binding ProteinsIFITM3 protein, humanleu-13 antigenAntigens, Differentiation

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Department of Physiology and Biophysics, Rush University, Chicago, IL 60612, USA.
  • Centre International de Recherche en Infectiologie (CIRI), Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Nationale Supérieure de Lyon, 69007 Lyon, France.
  • Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.

ORCID-Profile: Smita Verma, Gregory B Melikyan

Förderung

  • ANRS|MIE
  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • NIH/NIAID

Zitieren

APA

Verma, S., Prikryl, D., Marin, M., Markosyan, R. M., Cimarelli, A., & Melikyan, G. B. (2026). Divergent HIV-1 Restriction Phenotypes of IFITMs Expressed in Target Cells and Incorporated into Virions. Biomolecules, 16(3), 459. https://doi.org/10.3390/biom16030459

Vancouver

Verma S, Prikryl D, Marin M, Markosyan RM, Cimarelli A, Melikyan GB. Divergent HIV-1 Restriction Phenotypes of IFITMs Expressed in Target Cells and Incorporated into Virions. Biomolecules. 2026;16(3):459. doi:10.3390/biom16030459

BibTeX
@article{Verma2026,
  author = {Verma, Smita and Prikryl, David and Marin, Mariana and Markosyan, Ruben M and Cimarelli, Andrea and Melikyan, Gregory B},
  title = {Divergent HIV-1 Restriction Phenotypes of IFITMs Expressed in Target Cells and Incorporated into Virions},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {459},
  doi = {10.3390/biom16030459}
}
Kostenlos starten →